Planta Med 2003; 69(8): 765-767
DOI: 10.1055/s-2003-42795
Letter
© Georg Thieme Verlag Stuttgart · New York

Dual Effect of Saikogenin D: In vitro Inhibition of Prostaglandin E2 Production and Elevation of Intracellular Free Ca2+ Concentration in C6 Rat Glioma Cells

Yasuo Kodama1 , Lv Xiaochuan2 , Chikako Tsuchiya2 , Yasushi Ohizumi1 , Makoto Yoshida2 , Norimichi Nakahata2
  • 1Department of Pharmaceutical Molecular Biology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba, Aramaki, Aoba-ku, Sendai, Japan
  • 2Department of Cellular Signaling, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan
This work was partially supported by the grant-in-aid for Scientific Research (No. 14 572 049 to M.Y.; No. 14 370 737 to N.N.) from the Ministry of Education, Culture, Science, Sports and Technology of Japan, and by the grant-in-aid for special researcher (to L.X.) from Sasagawa Foundation
Weitere Informationen

Publikationsverlauf

Received: November 21, 2002

Accepted: April 26, 2003

Publikationsdatum:
06. Oktober 2003 (online)

Abstract

To clarify the pharmacological profile of saikogenin D, we examined the effect of saikogenin D on prostaglandin E2 (PGE2) production and intracellular free Ca2+ concentration ([Ca2+]i) in C6 rat glioma cells. Saikogenin D (1 - 20 μM) inhibited PGE2 production induced by the Ca2+ ionophore A23187 in a concentration-dependent manner with the IC50 of about 3 μM. Saikogenin D did not affect the conversion of arachidonic acid into PGE2 in microsomal preparations. On the other hand, saikogenin D elevated [Ca2+]i in a concentration-dependent manner (10 - 100 μM) with the EC50 value of about 35 μM in the presence or absence of extracellular Ca2+. These results suggest that saikogenin D possesses a dual effect: an inhibition of A23187-induced PGE2 production without a direct inhibition of cyclooxygenase activity; and an elevation of [Ca2+]i that is attributed to Ca2+ release from intracellular stores.

References

  • 1 Bermejo Benito P, Abad Martinez M J, Silvan Sen A M, Sanz Gomez A, Fernandez Matellano L, Sanchez Contreras S. et al . In vivo and in vitro anti-inflammatory activity of saikosaponins.  Life Sci. 1998;  63 1147-56
  • 2 Nishioka Y, Kyotani S, Miyamura M, Kusunose M. Influence of time of administration of a Shosaiko-to extract granule on blood concentration of its active constituents.  Chem Pharm Bull (Tokyo). 1992;  40 1335-7
  • 3 Dayton E T, Majo E O. Recombinant human interleukin 1 induces production of prostaglandins in primary human fetal astrocytes and immortalized human fetal astrocyte cultures.  J Neuroimmunol. 1996;  71 11-8
  • 4 Almer G, Teismann P, Stevie Z, Halaschek-Wiener J, Deecke L, Kostic V. et al . Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients.  Neurology. 2002;  58 1277-9
  • 5 Stephenson D T, Lemere C A, Selkoe D J, Clemens J A. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain.  Neurobiol Dis. 1996;  3 51-63
  • 6 Weaver J A, Maddox J F, Cao Y Z, Mullarky I K, Sordillo L M. Increased 15-HPETE production decreases prostacyclin synthase activity during oxidant stress in aortic endothelial cells.  Free Rad Biol Med. 2001;  30 299-308
  • 7 Matsushima T. Drug-induced pneumonitis and related diseases.  Nippon Naika Gakkai Zasshi. 1997;  86 457-62
  • 8 Nakatani K, Nakahata N, Arakawa T, Yasuda H, Ohizumi Y. Inhibition of cyclooxygenase and prostaglandin E2 synthesis by γ-mangostin, a xanthone derivative in mangosteen, in C6 rat glioma cells.  Biochem Pharmacol. 2002;  63 73-9
  • 9 Tsukii K, Nakahata N, Watanabe K, Tsurufuji S, Ohizumi Y. Comparison of tBuBHQ with chemotactic peptide and phorbol ester in O2 - production in HL-60 cells.  Eur J Pharmacol. 1996;  298 87-95
  • 10 Nakahata N, Ishimoto H, Mizuno K, Ohizumi Y, Nakanishi H. Dual effects of mastoparan on intracellular free Ca2+ concentrations in human astrocytoma cells.  Br J. Pharmacol 1994;  112 299-303

Norimichi Nakahata

Department of Cellular Signaling

Graduate School of Pharmaceutical Sciences

Tohoku University

Aoba

Aramaki

Aoba-ku

Sendai 980-8578

Japan

Telefon: +81-22-217-6809

Fax: +81-22-217-6809

eMail: nakahata@mail.pharm.tohoku.ac.jp

    >